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Folkman and Lazarus consider coping as cognitive and 
behaviour efforts to deal with external or internal de-
mands that are experienced beyond own resources11,12.
Stress and coping strategies assessment are very im-
portant for psoriatic patients because of inﬂ uence on clin-
ical outcome.
Maladaptive coping predicts disability so it is of utmost 
importance not only to assess clinical changes of skin but 
to assess level of stress and ways of coping with psoriasis13.
Patients can learn to abandon less useful coping strat-
egies and to adopt more efﬁ cient coping strategies14. It may 
be considered that if the patients have maladaptive coping 
mechanisms we can help them to develop more effective 
coping strategies that would lead to better overall clinical 
outcome.
Aims of this study are to determine which coping strat-
egies are used in psoriatic patients and to determine a 
relationship between clinical stages, stess level and differ-
ent ways of coping?
Stressful life events in response to psychosocial trigger 
have been reported to negatively affect the course of pso-
riasis and are regarded as preventable causes of morbid-
ity1–3.
Patients with high stress levels report an increased 
frequency of psoriasis when compared to people with low 
stress levels4–8.
Life stress events can activate the hypothalamus-pitu-
itary-adrenal axis and the sympathetic part of nervous 
system. Various soluble mediators like cortisol, catechol-
amine and neuropeptides can modulate the immune sys-
tem. Stress can reduce recovery time of the skin barrier 
after damage and change process of antigen presentation 
in Langerhans cells of epidermis4. In situation when stress 
levels are high enough to disrupt homeostasis physical or 
psychosocial symptoms may appear.
Coping with psoriasis is not only dealing with clinical 
changes on the skin but also coping with underlining psy-
chological processes9,10.
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 A B S T R A C T
Outbreaks of psoriasis usually can be linked with traumatic life stress events. Stressful life events in response to psy-
chosocial trigger have been reported to negatively affect the course of psoriasis and are regarded as preventable causes of 
morbidity. Aims of this study were to determine which coping strategies are mostly used in psoriatic patients and to de-
termine if there is a difference in coping according genders, clinical stages and stress level. The result shows that denial, 
active coping, seeking emotional support, positive reframing and acceptance are most frequently used among psoriatic 
patients. In adaptive coping psoriatic patients Psoriasis Area and Severity Index (PASI) score was 16.24, in maladaptive 
coping psoriatic patients PASI score was 19.6. Difference between adaptive and maladaptive coping strategies in psori-
atic patients according clinical stage measured by PASI score was not statistically signiﬁ cant. Psoriatic patients who had 
higher score of life stress events (461.57) measured by Life change units (LCU) used maladaptive coping statistically sig-
niﬁ cant more then patients with lower life stress events score (284.71). The results point to the need of psoriatic patients 
to learn how to cope with stress, enabling them to change ways of coping. There is need for integrating psychological in-
tervention into standard care protocol of chronic dermatologic disease as psoriasis.
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Subjects and Methods
This study is based on patients with psoriasis and con-
trol group verrucae vulgaris patients who were admitted 
over a period of one year to the dermatology ward of Gen-
eral hospital Karlovac. All included patients gave written 
consent and the project was authorised by the ethical com-
mittee of General hospital Karlovac.
Socio-demographic and clinical data were recorded 
from electronic data base of General hospital Karlovac.
Participants’ characteristics
In total of 244 patients with conﬁ rmed diagnosis of 
psoriasis (n=112) and control group (n=132). 172 (70.49%) 
were men and women were 72 (29.51%). Control group was 
otherwise healthy patients with verruca vulgaris. Married 
were 172 (70.49%), and divorced or widowed 72 (29.51%). 
Most of them ﬁ nished high school, mean duration of educa-
tion 11.6 years SD 2.95. Majority of patients lived in urban 
areas 158 (64.75%), in rural areas lived 86 (35.25%).
There were no statistical signiﬁ cant differences be-
tween the psoriatic and control group of patients with re-
gard to gender, age, level of education, marriage status 
and place of living.
The COPE Inventory was developed to assess a broad 
range of coping responses15–17.
The Brief COPE is abbreviated version of COPE Inven-
tory created on experiences with patient samples inpatient 
with the length of full instrument to solve burden and 
redundancy15–17. The factor structure is consistent with the 
full version of the COPE.
The Brief COPE that is used in this study consists of 
28 questions measuring 14 coping strategies that are pre-
sumable adaptive or maladaptive16.
Inventory includes six presumable maladaptive strate-
gies (denial, behavioural disengagement, substance use, 
venting, self-blame and self-distraction). There are eight 
presumable adaptive strategies (active coping, seeking 
emotional support, positive reframing, seeking instrumen-
tal support, planning, humour, acceptance, religion). Most 
frequently used coping strategies scored 5–8, less fre-
quently used strategies scored 2–4.
Fourteen coping strategies were collapsed into two: 
adaptive and maladaptive15,16.
Brief COPE was translated in Croatian and has been 
previously used in Croatian patients18. Cronbach’s alpha 
coefﬁ cient was used for internal validation of the instru-
ments and a rate of 0.60 was considered good internal 
consistency18.
The magnitude of each stressful life event reported by 
subjects was scored by two independent investigators, 
blinded to participants’ stress and clinical status, using 
the Recent Life Changes Questionnaire (RLCQ)19,20. This 
validated scale lists 91 different life events that can lead 
to stress and assigns a numerical value (Life change unit- 
LCU) ranging from 18 to 123 to the level of stress the 
event causes19.
Recent Life Changes Questionnaire was translated in 
Croatian and has been previously used in Croatian pa-
tients. Cronbach’s alpha coefﬁ cient was used for internal 
validation of the instruments and a rate of 0.71 was con-
sidered good internal consistency.
Psoriasis Area and Severity Index (PASI) is a tool for 
the measurement of clinical severity of psoriasis that com-
bines the assessment of the severity of lesions and the area 
affected into a single score in the range 0 (no disease) to 
72 (maximal disease)21.
The descriptive statistics are presented as means ± 
standard deviation. Correlation analysis (Pearson’s r) was 
used to examine the associations between the continuous 
variables. Chi-square and t test were used for the differ-
ence in two proportions. A data analysis was conducted 
using the Statistical Package for Social Sciences (v18.0, 
SPSS Inc., Chicago, IL). The statistical signiﬁ cance was 
estimated at the level of p<0.05.
Results
The results show that denial, active coping, seeking 
emotional support, positive reframing and acceptance are 
the most frequently used among psoriatic patients. The 
coping strategies used the least are denial and substance 
use. There were no statically signiﬁ cant difference be-
tween adaptive and maladaptive coping strategies com-
paring psoriatic patients and the control group (Table 1).
Difference in coping strategies between psoriasis and 
the control group show us that self-blame and planning 
strategies are statistically signiﬁ cantly more used in con-
trol group (verrucae vulgaris patients). Psoriatic patients 
used more then control group avoidance, emotional sup-
port and religion as coping strategies but the differences 
were not statistically signiﬁ cant.
Men with psoriasis statistically signiﬁ cantly use more 
of humour, planning and self-blame, and women statisti-
cally signiﬁ cantly use more acceptances.
Denial was statistically signiﬁ cantly correlated with 
higher level of stress and higher PASI score in psoriatic 
patients (r= 0.13, p<0.03), and venting coping strategy 
statistically signiﬁ cantly correlated with higher level of 
stress and higher PASI score in psoriatic patients (r= 0.14, 
p<0.02).
TABLE 1
DIFFERENCES BETWEEN PSORIASIS AND CONTROL GROUP 
IN ADAPTIVE/MALADAPTIVE WAYS OF COPING
Way of coping Adaptive Maladaptive p
Psoriasis 80 32
0.83
Control group 92 40
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Negative correlations for higher level of stress were use 
of religion and positive reframing but that was not statis-
tically signiﬁ cant.
Difference between adaptive and maladaptive coping 
strategies in psoriatic patients was not statistically sig-
niﬁ cant according PASI score (Table 2), but psoriatic pa-
tients who had higher score of life stress events used mal-
adaptive coping statistically signiﬁ cant more then patients 
with lower life stress events score (Table 2).
Discussion and Conclusion
The study has focused on how patients with psoriasis 
cope with their illness. 
There are limited studies demonstrating coping strat-
egies in patients with psoriasis. Psoriatic patients as a 
whole tended to use signiﬁ cantly less active coping strate-
gies, planning and positive reinterpretation and humour 
when compared to healthy control8, 22–25. Psoriatic patients 
who use emotional coping styles report more disability and 
have worse quality of life24,26. Seeking emotional support 
was one of the most used coping modality in our study. Of 
notice is the fact that the self-control and the escape-avoid-
ance strategies are employed signiﬁ cantly more often by 
the psoriasis group when compared to the control group27. 
Finzi conducted a study where active coping and planning 
have been reported to be the most used coping strategy by 
patients with psoriasis, same were ours results28,29.
Scharloo demonstrated that coping strategies and dis-
ease perceptions inﬂ uence on health outcome and patients 
with higher level of perceived control and greater expres-
sion of emotion have better health outcomes over the 
course of a year then those engaging in passive and avoid-
ant coping behaviour30.
The result of our study shows that denial, active cop-
ing, seeking emotional support, positive reframing and 
acceptance are most frequently used among psoriatic pa-
tients.
Coping strategies can be adaptive or maladaptive, in 
our study there was no statistically signiﬁ cant difference 
between adaptive and maladaptive coping strategies ac-
cording PASI score in psoriatic patients. Psoriatic patients 
who had higher score of life stress events used maladap-
tive coping statistically signiﬁ cant more then patients 
with lower life stress events score.
Planning and active coping are the most commonly 
employed by psoriatic patients23,28. Similar results are in 
our study of psoriatic patients.
Patients with psoriasis avoid confronting the stressful 
situations attempting to control emotions. Self-control and 
escape-avoidance strategies are used more often by psori-
atic group of patients.
Denial is very important coping mechanism but it can 
delay treatment and it is the best predictor of compliance22. 
In our study denial is one of most common way of coping 
in psoriasis patients and positive correlated with higher 
PASI score and life stress score.
Venting is positive correlated with higher PASI score 
and life stress score that can be explained that it is very 
efﬁ cient coping strategy especially in seriously ill patients.
There was no statistically signiﬁ cant difference in 
adaptive/maladaptive coping between psoriasis patients 
and control group. We can explain this with the fact that 
most of chronic skin diseases have same coping pattern.
Self-blame and planning are signiﬁ cantly more often 
used way of coping in control group (HPV infection ver-
ruca vulgaris patients) because they think that their risky 
behaviour caused illness.
Psoriatic patients tend to use more religion for coping 
and they are less directed towards social network and 
support. In our study religion was least used way of cop-
ing. The reason for this is that religion is more part of our 
culture and not of deep emotional and psychological na-
ture.
Our study showed that men with psoriasis statisti-
cally signiﬁ cantly use more of humour, planning and self-
blame, and women statistically signiﬁ cantly use more 
acceptances. Difference in the use of coping strategies 
showed that women tend to use greater number of coping 
strategies than males and that women use more adaptive 
coping.
Women uses tend and befriend strategy and men use 
ﬁ ght and ﬂ ight strategy, Finzi founded that female gender 
was the most important predictive factor for psychological 
distress28.
In our study psoriatic patients who had higher score of 
life stress events used maladaptive coping statistically 
signiﬁ cant more then patients with lower life stress events 
score. On the other hand there were no statistically sig-
niﬁ cant according PASI score of clinical stage of psoriasis.
Despite of greater disability patients with severe pso-
riasis in ways of coping did not signiﬁ cantly different form 
moderate psoriasis patients. Life stress is more important 
predictor of maladaptive coping then mere clinical status 
of patients.
Use of adaptive coping strategy is related to better so-
cial and psychological functions of the patients and with 
better clinical outcome8,24,25.
This study has the limitations of providing retrospec-
tive access to patients past history data and explaining 
the causal sequence among variables.
TABLE 2
DIFFERENCES BETWEEN ADAPTIVE AND MALADAPTIVE 
COPING ACCORDING CLINICAL STAGE OF PSORIASIS AND 
STRESS LEVEL
Way of coping adaptive maladaptive p
PASI score   16.24    19.61 0.28
Standard Deviation   12.94   15.97
LCU score 284.71 461.57 0.04
Standard Deviation 224.64 254.82
PASI – Psoriasis Area and Severity Index
LCU – Life Change Unit
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The results point to the need of psoriatic patients to 
learn how to cope with stress, enabling them to change 
ways of coping. Patients can be taught to adopt most suc-
cessful adaptive strategies of coping.
There are need for integrating psychological interven-
tion especially stress management into standard care 
protocol of chronic dermatologic disease as psoriasis.
Understanding their diverse coping mechanism can 
give psoriatic patients chance for better therapy.
There are needs for integrating psychological interven-
tion into standard care protocol of chronic dermatologic 
disease as psoriasis.
The results point to the need of psoriatic patients to 
learn how to cope with stress, enabling them to take ac-
tions and to change ways of coping.
R E F E R E N C E S
1. BERG M, SVENSSON M, BRANDBERG M, NORDLIND K, J Eur 
Acad Dermatol Venereol, 22 (2008) 670. DOI: 10.1111/j.1468-3083. 
2008.02642. — 2. VERHOEVEN EW, KRAAIMAAT FW, JONG EM, 
SCHALKWIJK J, VAN DE KERKHOF C, EVERS, AW, J Invest Derma-
tol, 129 (2009) 2075. DOI: 10.1038/jid.2008.460. — 3. BULJAN D, BUL-
JAN M, ŠITUM M, Psychiatr Danub, 17 (2005) 76. — 4. HALL JM, 
CRUSER D, PODAWILTZ A, MUMMERT DI, JONES H, MUMMERT 
MM, Dermatol Res Pract, 2012 (2012) 403908. DOI: 10.1155/2012/403908. 
— 5. BILJAN D, LAUFER D, FILAKOVIĆ P, ŠITUM M, BRATA LJE-
NOVIĆ T, Coll Antropol, 33 (2009) 889. — 6. DELLAVALLE RP, JOHN-
SON KR, J Invest Dermatol, 125 (2005) 6. — 7. PICEK P, BULJAN D, 
ROGULJ A, STIPETIĆ-OVČARIĆEK J, ČATIĆ A, PLE ŠTINA S, VUČI-
ĆEVIĆ BORAS V, VIDOVIĆ-JURAS D, Coll Antropol, 36 (2012) 157. 
— 8. JANKOVIĆ S, RAZNATOVIĆ M, MARINKOVIĆ J, MAKSI MOVIĆ 
N, JANKOVIĆ J, DJIKANOVIĆ B, Acta Derm Venereol, 89 (2009) 364. 
DOI: 10.2340/00015555-0669. — 9. SATHYANARAYANA RTS, BASA-
VARAJ KH, DAS K, Indian J Psychiatry, 55 (2013) 313. DOI: 10.4103/ 
0019-5545.120531. — 10. HUYNH M, GUPTA R, KOO JY, Semin Cutan 
Med Surg, 32 (2013) 68. — 11. LAZARUS RS, Psychosom Med, 55 (1993) 
234. — 12. WAHL A, HANESTAD BR, WIKLUND I, MOUM T, Qual 
Life Res, 8 (1999) 427. — 13. HILL L, KENNEDY P, Psychol Health, 7 
(2002) 261. — 14. BILLINGS AG, MOOS RH, J Behav Med, 4 (1981) 139. 
— 15. CARVER CS, SCHEIER MF, WEINTRAUB JK, J Pers Soc Psy-
chol, 56 (1989) 267. — 16. MEYER B, J Psychopathol Behav, 23 (2001) 
265. — 17. SCHEIER MF, WEINTRAUB JK, CARVER, CS, J Pers Soc 
Psychol, 51 (1986) 1257. − 18. GENC A, PEKIĆ JJ, MATANOVIĆ J, 
Primenjena psihologija, 6 (2013) 155. — 19. MILLER MA, RAHE RH, J 
Psychosom Res, 43 (1997) 279. — 20. HOLMES TH, RAHE RH, J Psy-
chosom Res, 11 (1967) 213. — 21. FREDRIKSSON T, PETTERSSON U, 
Dermatologica, 157 (1978) 238. DOI: 10.1159/000250839. — 22. GUD-
JONSSON GH, SIGURDSSON JF, Eur J Psych Assess, 19 (2003) 117. 
DOI: 10.1027//1015-5759.19.2.117. — 23. FORTUNE DG, RICHARDS 
HL, MAIN CJ, GRIFFITHS CE, Clin Exp Dermatol, 27 (2002) 177. — 24. 
SELIC P, PETEK D, SEREC M, RUS MAKOVEC M, Coll Antropol, 36 
(2012) 1175. — 25. FAZLIĆ H, BRBOROVIĆ O, VUKUŠIĆ RUKAVINA 
T, FIŠTER K, MILOŠEVIĆ M, MUSTAJBEGOVIĆ J, Coll Antropol, 36 
Suppl 1 (2012) 165. DOI: dx.doi.org/10.5671/ca.2012361s.165. — 26. AL-
TUNAY I, DONER N, MERCAN S, GULSEN TDG, Dermatologica Sini-
ca, 31 (2013) 130. DOI: 10.1016/j.dsi.2013.02.001. — 27. SILVA JDT, 
MÜLLER MC, BONAMIGO RR, An Bras Dermatol, 81 (2006) 143. — 28. 
FINZI A, COLOMBO D, CAPUTO A, ANDREASSI L, CHIMENTI S, 
VENA G, SIMONI L, SGARBI S, GIANNETTI A, J Eur Acad Dermatol 
Venereol, 21 (2007) 1161. DOI: 10.1111/j.1468-3083.2007.02079.x. — 29. 
RAPP SR, FELDMAN SR, EXUM ML, FLEISCHER AB, REBOUSSIN 
DM, J Am Acad Dermatol (1999) 401. — 30. SCHARLOO M, KAPTEIN, 
AA, WEINMAN, J, HAZES, JM, WILLEMS LN, BERGMAN W, ROOI-
JMANS H.G, J Psychosom Res, 44 (1998) 573. DOI: 10.1016/S0022-
3999(97)00254-7.
H. Cvitanović
Department of dermatovenereology, General hospital Karlovac, Andrije Štampara 3, 47000 Karlovac, Croatia
hrvoje.cvitanovic@bolnica-karlovac.hr
UTJECAJ ŽIVOTNIH STRESNIH DOGAĐAJA NA SUOČAVANJE U PSORIJAZI
S A Ž E T A K
Pojava, a napose pogoršanje psorijaze je povezano s životnim stresnim događajima koji kao značajan psihoscijalni 
čimbenik negativno utječu na tijek bolesti. Smatra se da utjecajem na smanjenje i kontrolu stresa mogu se prevenirati 
ili ublažiti simptomi psorijaze. Cilj ovog rada je utvrditi koje strategije suočavanja sa stresom su najčesšće upotrebljene 
u bolesnika s psorijazom te da li postoje razlike u načinima suočavanja obzirom na spol, kliničko stanje i razinu stresa. 
Bolesnici s psorijazom najčešće upotrebljavanju kao način suočavanja: negiranje, aktivno suočavanje, traženje emocio-
nalne podrške, ponovno promišljanje te prihvaćanje. S obzirom na kliničko stanje prema Psoriasis Area and Severity 
Index (PASI) nije bilo statistički značajne razlike u bolesnika koji upotrebljavanju adaptivni način suočavanja (PASI 
16,24) u odnosu na bolesnike koji upotrebljavaju maladaptivne načine suočavanja (PASI 19,6). Bolesnici s psorijazom 
koji su imali značajniju izloženost životnim stresnim događajima mjereno prema Upitniku nedavnih životnih događaja 
(Life change units – LCU 461,57) statistički su značajnije upotrebljavali maldaptivne načine suočavanja sa stresom nego 
bolesnici koji su imali manji broj životnih stresnih događaja (LCU 284,71). Rezultati pokazuju potrebu da bolesnici s 
psorijazom nauče kako se suočavati sa stresom te da im se omogući psihološka potpora da promjene načine suočavanja. 
Psihološka intervencija bi trebala bti dio standardnog postupovnika u liječenju kronične kožne bolesti kao što je psorijaza.
